The plaintiffs found initial success in a 2-1 decision in their favor by the Court of Appeals for the [[D.C. Circuit]]. However, an [[en banc]] sitting of that court then overwhelming reversed that initial panel decision, and held that there should not be a new constitutional right to potentially lifesaving treatment. The court expressed concern that a new constitutional right may become a slippery slope to demand [[stem cell]] research or other controversial and unproven treatments. | The plaintiffs found initial success in a 2-1 decision in their favor by the Court of Appeals for the [[D.C. Circuit]]. However, an [[en banc]] sitting of that court then overwhelming reversed that initial panel decision, and held that there should not be a new constitutional right to potentially lifesaving treatment. The court expressed concern that a new constitutional right may become a slippery slope to demand [[stem cell]] research or other controversial and unproven treatments. |